Opportunistic 'rediscovery' of mental disorders by the pharmaceutical industry

Psychotherapy and Psychosomatics

Volumn 71, Issue 6, 2002, Pages 305-310

  Starcevic, Vladan ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEPEAN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROFAROMINE; FLUOXETINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANXIETY DISORDER; AWARENESS; DRUG APPROVAL; DRUG INDUSTRY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GENERALIZED ANXIETY DISORDER; HUMAN; MENTAL DISEASE; MENTAL HEALTH; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT EDUCATION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PUBLICATION; SCHIZOPHRENIA; SOCIAL PHOBIA;

ANTIDEPRESSIVE AGENTS; DRUG INDUSTRY; HUMANS; MENTAL DISORDERS;

EID: 0036971012     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065989     Document Type: Editorial

References (26)

1. Fava GA: All our dreams are sold. Psychother Psychosom 1998;67:191-193.
2. Stelfox HT, Chua G, O'Rourke K, Detsky AS: Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101-106.
3. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL: Evaluation of conflict of interest in economic analysis of new drugs used in oncology. JAMA 1999;282:1453-1457.
4. Fava GA: Conflict of interest and special interest groups. The making of a counter culture. Psychother Psychosom 2001;70:1-5.
5. Krimsky S: Journal policies on conflict of interest: If this is the therapy, what's the disease? Psychother Psychosom 2001;70:115-117.
6. Garfinkel PE: The changing culture related to the practice of psychiatry. Psychother Psychosom 2001;70:227-231.
7. Jureidini J, Mansfield P: Does drug promotion adversely influence doctors' abilities to make the best decisions for patients? Australas Psychiatry 2001;9:95-99.
8. Gelenberg AJ: Grow the market. J Clin Psychiatry 2001;62:589.
9. Healy D: The Antidepressant Era. Cambridge, Harvard University Press, 1997.
10. Klerman GL: Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 1988;45:407-412.
11. Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. 1. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422.
12. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF: Social phobia: Review of a neglected anxiety disorder. Arch Gen Psychiatry 1985;42:729-736.
13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
14. Weiller E, Bisserbe JC, Boyer P, Lepine JP, Lecrubier Y: Social phobia in general health care: An unrecognised undertreated disabling disorder. Br J Psychiatry 1996;168:169-174.
15. Wittchen H-U, Beloch E: The impact of social phobia on quality of life. Int Clin Psychopharmacol 1996;11(suppl 3):15-23.
16. The World Psychiatric Association Social Phobia Task Force: Pocket Reference to Social Phobia. London, Science Press, 1995.
17. Westenberg HGM, den Boer JA (eds): Focus on Psychiatry: Social Anxiety Disorder. Amsterdam, Syn-Thesis, 1999.
18. Markway BG, Markway GP: Painfully Shy: How to Overcome Social Anxiety and Reclaim Your Life. New York, St. Martins, 2001.
19. Kessler RC: The epidemiology of pure and comorbid generalized anxiety disorder: A review and evaluation of recent research. Acta Psychiatr Scand Suppl 2000;(406):7-13.
20. Hunt C: The diagnosis and nature of generalized anxiety disorder. Curr Opin Psychiatry 2000;13:157-161.
21. Kessler RC, DuPont RL, Berglund P, Wittchen H-U: Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999;156:1915-1923.
22. Hollander E: Obsessive-compulsive spectrum disorders: An overview. Psychiatr Ann 1993;23:355-358.
23. Bero LA, Galbraith A, Rennie D: The publication of sponsored symposiums in medical journals. N Engl J Med 1992;327:1135-1140.
24. Ballenger JC, Pecknold J, Rickels K, Sellers EM: Medication discontinuation in panic disorder. J Clin Psychiatry 1993;54(suppl 10):15-24.
25. Breier A, Charney DS, Heninger GR: The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 1985;142:787-797.
26. Argyropoulos SV, Hood SD, Nutt DJ: Social phobia: Illness or illusion? Acta Psychiatr Scand 2001;103:241-243.